uniQure: Community Letter Regarding the Recent FDA Type A Meetingkatrina4384Mar 21 min readFor ANY questions: medinfo@uniqure or 1-866-520-1257
Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease
Comments